Abstract:The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic has been validated as an extreme clinical calamity and has affected several socio-economic activities globally. Proven transmission of this virus occurs through airborne droplets from an infected person. The recent upsurge in the number of infected individuals has already exceeded the number of intensive care beds available to patients. These extraordinary circumstances have elicited the need for the development of diagnostic tools for the detection of the virus and, hence, prevent the spread of the disease. Early diagnosis and effective immediate treatment can reduce and prevent an increase in the number of cases. Conventional methods of detection such as quantitative real-time polymerase chain reaction and chest computed tomography scans have been used extensively for diagnostic purposes. However, these present several challenges, including prolonged assay requirements, labor-intensive testing, low sensitivity, and unavailability of these resources in remote locations. Such challenges urgently require fast, sensitive, and accurate diagnostic techniques for the timely detection and treatment of coronavirus disease 2019 (COVID-19) infections. Point-of-care biosensors that include paper- and chip-based diagnostic systems are rapid, cost-effective, and user friendly. In this article nanotechnology-based potential biosensors for SARS-CoV-2 diagnosis are discussed with particular emphasis on a lateral flow assay, a surface-enhanced Raman scattering-based biosensor, a localized surface plasmon resonance-based biosensor, Förster resonance energy transfer, an electrochemical biosensor, and artificial intelligence-based biosensors. Several biomolecules, such as nucleic acids, antibodies/enzymes, or aptamers, can serve as potential detection molecules on an appropriate platform, such as graphene oxide, nanoparticles, or quantum dots. An effective biosensor can be developed by using appropriate combinations of nanomaterials and technologies.

Review—Role of Nanomaterials in Screenprinted Electrochemical Biosensors for Detection of Covid-19 and for Post-Covid Syndromes

Nanomaterials-based electrochemical biosensors for diagnosis of COVID-19

Electrochemical investigations for COVID-19 detection-A comparison with other viral detection methods

Smart and emerging point of care electrochemical sensors based on nanomaterials for SARS-CoV-2 virus detection: Towards designing a future rapid diagnostic tool

Functional Nanomaterials for Electrochemical SRAS-CoV-2 Biosensors: a Review

Functional Nanomaterials for Rapid Detection of SARS-CoV-2: a Review

A Review on Potential Electrochemical Point-of-Care Tests Targeting Pandemic Infectious Disease Detection: COVID-19 as a Reference

Nanomaterial-Based Biosensors for the Detection of COVID-19

An overview of electrochemical biosensors used for COVID-19 detection

Nanomaterials to tackle the COVID-19 pandemic

Nanomaterials and Biosensing Technology for the SARS-CoV-2 Detection

Recent Developments in Nanotechnology-Based Biosensors for the Diagnosis of Coronavirus

Nanotechnology-Based Approaches for the Detection of SARS-CoV-2

Recent Advances in Electrochemical and Nanophotonic Biosensors for SARS-CoV-2 Detection

Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19

Electrochemical and Bioelectrochemical Sensing Platforms for Diagnostics of COVID-19

ZnO Nanoflower-Based Electrochemical SARS-CoV-2 Molecular Biosensors with Improved Diagnostic Accuracy

Cutting-edge biorecognition strategies to boost the detection performance of COVID-19 electrochemical biosensors: A review

COVID-19 diagnosis on the basis of nanobiosensors' prompt interactivity: A holistic review

Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses

Metallic nanoplatforms for COVID-19 diagnostics: versatile applications in the pandemic and post-pandemic era